Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E S, Sunila"'
Publikováno v:
Arzneimittelforschung. 62:14-17
ET B receptor agonist, IRL-1620 (or SPI-1620) presently in US Phase 1 clinical trial, has been demonstrated to selectively and transiently increase tumor blood flow. The present study was conducted to determine the effect of IRL-1620 on radiation the
Publikováno v:
Pharmaceutical biology. 49(10)
Tumor microenvironment induces an active immune tolerance and escapes immune surveillance. In order to achieve an effective antitumor immune response, appropriately activated immune cells should maintain their antitumor activity to overcome the immun
Autor:
K B Hari, Kumar, E S, Sunila, Girija, Kuttan, K C, Preethi, C Nimita, Venugopal, Ramadasan, Kuttan
Publikováno v:
Asian Pacific journal of cancer prevention : APJCP. 8(1)
Homeopathy is considered as one modality for cancer therapy. However, there are only very few clinical reports on the activity of the drugs, as well as in experimental animals. Presently we have evaluated the inhibitory effects of potentized homeopat
Publikováno v:
Integrative cancer therapies. 4(4)
Angiogenesis is a process by which new blood vessels are formed from preexisting vessels. New blood vessel formation by angiogenesis involves the degradation of extra-cellular matrix combined with sprouting and migration of endothelial cells from pre
Autor:
G. Kuttan, E. S. Sunila
Publikováno v:
Integrative cancer therapies. 4(4)
The effect of Thuja occidentalisagainst damage induced by γ radiation was studied. Whole-body exposure of Swiss albino mice to γ-rays (6 Gy) reduced the total white blood cell count to 1900 cells/mm3on the third day, which was elevated to 2050 cell
Autor:
E. S. Sunila
Publikováno v:
Integrative Cancer Therapies; Dec2005, Vol. 4 Issue 4, p322-328, 7p